LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies.

Faour, Wissam H / Choaib, Ali / Issa, Elio / Choueiry, Francesca El / Shbaklo, Khodor / Alhajj, Maryline / Sawaya, Ramy Touma / Harhous, Zeina / Alefishat, Eman / Nader, Moni

Inflammation research : official journal of the European Histamine Research Society ... [et al.

2021  Volume 71, Issue 1, Page(s) 39–56

Abstract: The COVID-19 pandemic created a worldwide debilitating health crisis with the entire humanity suffering from the deleterious effects associated with the high infectivity and mortality rates. While significant evidence is currently available online and ... ...

Abstract The COVID-19 pandemic created a worldwide debilitating health crisis with the entire humanity suffering from the deleterious effects associated with the high infectivity and mortality rates. While significant evidence is currently available online and targets various aspects of the disease, both inflammatory and noninflammatory kidney manifestations secondary to COVID-19 infection are still largely underrepresented. In this review, we summarized current knowledge about COVID-19-related kidney manifestations, their pathologic mechanisms as well as various pharmacotherapies used to treat patients with COVID-19. We also shed light on the effect of these medications on kidney functions that can further enhance renal damage secondary to the illness.
MeSH term(s) Acute Kidney Injury/complications ; Aldosterone/metabolism ; Angiotensins/chemistry ; Antibodies, Monoclonal, Humanized/administration & dosage ; Autopsy ; Biopsy ; COVID-19/complications ; COVID-19/drug therapy ; COVID-19/physiopathology ; COVID-19 Vaccines ; Dexamethasone/administration & dosage ; Enoxaparin/administration & dosage ; Heparin/administration & dosage ; Heparin, Low-Molecular-Weight/administration & dosage ; Humans ; Inflammation ; Interleukin 1 Receptor Antagonist Protein/administration & dosage ; Kidney/injuries ; Kidney Diseases/complications ; Kidney Diseases/physiopathology ; Kidney Transplantation ; Lopinavir/administration & dosage ; Pandemics ; Renal Replacement Therapy ; Renin-Angiotensin System ; Ritonavir/administration & dosage ; SARS-CoV-2
Chemical Substances Angiotensins ; Antibodies, Monoclonal, Humanized ; COVID-19 Vaccines ; Enoxaparin ; Heparin, Low-Molecular-Weight ; Interleukin 1 Receptor Antagonist Protein ; Lopinavir (2494G1JF75) ; Aldosterone (4964P6T9RB) ; Dexamethasone (7S5I7G3JQL) ; Heparin (9005-49-6) ; tocilizumab (I031V2H011) ; Ritonavir (O3J8G9O825)
Language English
Publishing date 2021-11-21
Publishing country Switzerland
Document type Journal Article ; Review
ZDB-ID 1221794-3
ISSN 1420-908X ; 1023-3830
ISSN (online) 1420-908X
ISSN 1023-3830
DOI 10.1007/s00011-021-01520-8
Shelf mark
Zs.A 675: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top